Immune to Cancer: The CRI Blog
-
Marguerite Sullivan’s Immunotherapy Story
Melanoma | Diagnosed 2012 I truly feel I’m here because of immunotherapy. Marguerite’s Story For Marguerite Sullivan, 63,… -
AACR21 Recap: CRI Scientists Highlight the Latest in ‘Discovery Science Driving Clinical Breakthroughs’
During AACR21, CRI scientists highlighted how improving our understanding of basic immune biology may enable improved immunotherapies…
-
CRI Speaks with 2021 Lloyd J. Old Award Recipient Dr. Ton Schumacher
Dr. Ton Schumacher, 2021 Lloyd J. Old Award recipient, discusses his career accomplishments and the future of…
-
Esophageal Cancer Awareness Month: 2021 Immunotherapy Research Updates
This April for Esophageal Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Five Spring Fundraising Ideas for 2021
Spring equinox marks a moment of renewal. Why not choose a personal goal to invest in yourself…
-
Head and Neck Cancer Awareness Month: 2021 Immunotherapy Research Updates
This April for Head and Neck Cancer Awareness Month, we look at new research, new treatments, and…
-
What to Expect in Cancer Immunotherapy in 2021: COVID-19, Biomarkers, and Clinical Trial Design
Dr. Kunle Odunsi shares his thoughts on what lies ahead for the field of cancer immunotherapy.
-
Qué esperar de la inmunoterapia contra el cáncer en 2021: COVID-19, biomarcadores y modelos de ensayos clínicos
El Dr. Kunle Odunsi comparte sus reflexiones sobre el futuro en el campo de la inmunoterapia contra…
-
Las mujeres que erigieron el CRI y promovieron la inmunoterapia como tratamiento del cáncer
CRI highlights some of the many women who are and have been integral to our organization and…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.